{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T14:27:09Z","timestamp":1725460029374},"publisher-location":"Boston","reference-count":22,"publisher":"Kluwer Academic Publishers","isbn-type":[{"type":"print","value":"0306477572"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/0-306-48382-3_26","type":"book-chapter","created":{"date-parts":[[2006,2,18]],"date-time":"2006-02-18T20:57:40Z","timestamp":1140296260000},"page":"131-138","source":"Crossref","is-referenced-by-count":1,"title":["Acetylator Phenotype in Beh\u00e7et\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Rafid A.","family":"Najim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalifa E.","family":"Sharquie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmood H.","family":"Al-Janabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"26_CR1","first-page":"25","volume":"37","author":"W.W. Weber","year":"1985","unstructured":"Weber, W.W., and Hein, D.W., 1985, N-acetylation pharmacogenetics. Pharmacol. Rev. 37: 25\u201379.","journal-title":"Pharmacol. Rev."},{"key":"26_CR2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jps.2600720527","volume":"72","author":"M.L. Chen","year":"1983","unstructured":"Chen, M.L., Lee M.G., and Chiou W.L., 1983, Pharmacokinetics of drugs in blood III: Metabolism of procainamide and storage effects of blood samples. J. Pharma. Sci. 72: 572\u2013574.","journal-title":"J. Pharma. Sci."},{"key":"26_CR3","first-page":"186","volume":"13","author":"K.E. Sharquie","year":"1990","unstructured":"Sharquie, K.E., 1990, Beh\u00e7et\u2019s disease. Postgrad. Doctor Middle East 13: 186\u2013190.","journal-title":"Postgrad. Doctor Middle East"},{"key":"26_CR4","first-page":"1152","volume":"105","author":"H. Beh\u00e7et","year":"1937","unstructured":"Beh\u00e7et, H., 1937, \u00dcber rezidivierende aphth\u00f6se, durch ein virus verursachte Geschw\u00fcre am Mund am Auge und den Genitalien. Dermatol. Wochenschr. 105: 1152\u20131157.","journal-title":"Dermatol. Wochenschr."},{"key":"26_CR5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2133.1984.tb04665.x","volume":"110","author":"K. Sharquie","year":"1984","unstructured":"Sharquie K., 1984, Suppression of Beh\u00e7et\u2019s disease with dapsone. Br. J. Dermatol. 110: 493\u2013494.","journal-title":"Br. J. Dermatol."},{"key":"26_CR6","doi-asserted-by":"crossref","unstructured":"Sharquie, K., Najim, R.A., and Abu-Raghif, A.R., 2002, Dapsone in treatment of Beh\u00e7et\u2019s disease: a double blind, placebo-controlled crossover study. J. Dermatol., in press.","DOI":"10.1111\/j.1346-8138.2002.tb00263.x"},{"key":"26_CR7","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s disease, 1990, Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet 335: 1078\u20131080.","journal-title":"Lancet"},{"key":"26_CR8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2125.1984.tb02373.x","volume":"17","author":"P.A. Philip","year":"1984","unstructured":"Philip, P.A., Gayed, S.L., and Rogers, H.J., 1984, A rapid method for determination of acetylation phenotype using dapsone. Br. J. Clin. Pharmacol. 17: 465\u2013469.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"26_CR9","first-page":"47","volume-title":"Medical Biostatistics and Epidemiology: Examination and Board review","author":"D.E. Sorlie","year":"1995","unstructured":"Sorlie, D.E., 1995, Medical Biostatistics and Epidemiology: Examination and Board review. 1st ed., Appleton and Lange, Norwalk, Connecticut, pp. 47\u201388.","edition":"1st ed."},{"key":"26_CR10","unstructured":"Friedman, J.M., 1996, Population genetics. In Genetics (Friedman, J.M., ed.), 2nd ed., pp. 105\u2013111."},{"key":"26_CR11","unstructured":"Ahmad, R.A., 1984, Acetylation in Iraqi population. In Proceeding of the First Scientific Congress, College of Medicine, University of Baghdad, p. 115."},{"key":"26_CR12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2125.1991.tb03901.x","volume":"32","author":"Y.M. Irashaid","year":"1991","unstructured":"Irashaid, Y.M., Al-Hadidi H.F., Aburijeie, M.A., et al., 1991, N-acetylation phenotyping using dapsone in a Jordanian population. Br. J. Clin. Pharmacol. 32: 289\u2013293.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"26_CR13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/00498258209052472","volume":"12","author":"S.I. Islam","year":"1982","unstructured":"Islam, S.I., 1982, Polymorphic acetylation of sulphamethazine in rural Bedouin and urban dwellers in Saudi Arabia. Xenobiotica 12: 323\u2013328.","journal-title":"Xenobiotica"},{"key":"26_CR14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/jmg.18.5.325","volume":"18","author":"A.K.M.B. Karim","year":"1981","unstructured":"Karim, A.K.M.B., Elferah, M.S., and Evans, D.A.P., 1981, Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution. J. Med. Genet. 18: 325\u2013330.","journal-title":"J. Med. Genet."},{"key":"26_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/ajpa.1330310114","volume":"31","author":"N. Hashem","year":"1969","unstructured":"Hashem, N., Khalifa, S., and Nour, A., 1969, The frequency of isoniazide acetylase enzyme deficiency among Egyptians. Am. J. Phys. Anthropol. 31: 97\u2013102.","journal-title":"Am. J. Phys. Anthropol."},{"key":"26_CR16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/clpt.1983.45","volume":"33","author":"D.M. Grant","year":"1983","unstructured":"Grant, D.M., Tang, B.K., and Kalow, W., 1983, Polymorphic N-acetylation of a caffeine metabolite. Clin. Pharmacol. Ther. 33: 355\u2013359.","journal-title":"Clin. Pharmacol. Ther."},{"key":"26_CR17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2125.1988.tb03333.x","volume":"25","author":"Y. Horai","year":"1988","unstructured":"Horai, Y., and Ishizaki, T., 1988, N-acetylation polymorphism of dapsone in a Japanese population. Br. J. Clin. Pharmacol. 25: 487\u2013494.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"26_CR18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/j.1552-4604.1989.tb03321.x","volume":"29","author":"A. El-Yazigi","year":"1989","unstructured":"El-Yazigi, A., Chaleby, K., and Martin, C.R., 1989, Acetylator phenotypes of Saudi Arabians by a simplified caffeine metabolites test. J. Clin. Pharmacol. 29: 246\u2013250.","journal-title":"J. Clin. Pharmacol."},{"key":"26_CR19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/ard.39.4.344","volume":"39","author":"H. Yazici","year":"1980","unstructured":"Yazici, H., Chamberlain, M.A., Schreuder, T., et al., 1980, HLA antigen in Beh\u00e7et\u2019s disease: A reapprasial by a comperative study of Turkish and British patients. Ann. Rheum. Dis. 39: 344.","journal-title":"Ann. Rheum. Dis."},{"key":"26_CR20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/ard.45.12.987","volume":"45","author":"Z.S. Al-Rawi","year":"1986","unstructured":"Al-Rawi, Z.S., Sharquie, K.E., Khalifa, S.J., et al., 1986, Beh\u00e7et\u2019s disease in Iraqi patients. Ann. Rheum. Dis. 45: 987\u2013990.","journal-title":"Ann. Rheum. Dis."},{"key":"26_CR21","first-page":"458","volume":"2","author":"D.A.P. Evans","year":"1960","unstructured":"Evans D.A.P., Manley K.A., and Mckusick, V.A., 1960, Genetic control of isoniazide metabolism in man. Br. Med. J. 2: 458\u2013491.","journal-title":"Br. Med. J."},{"key":"26_CR22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00003088-198611040-00003","volume":"11","author":"J. Zuidema","year":"1986","unstructured":"Zuidema, J., Hilbers, E.S., and Merkus A., 1986, Clinical pharmacokinetics of dapsone. Clin. Pharmacokinet. 11: 299\u2013314.","journal-title":"Clin. Pharmacokinet."}],"container-title":["Advances in Experimental Medicine and Biology","Adamantiades-Beh\u00e7et\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/0-306-48382-3_26.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T04:30:51Z","timestamp":1619497851000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/0-306-48382-3_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["0306477572"],"references-count":22,"URL":"https:\/\/doi.org\/10.1007\/0-306-48382-3_26","relation":{},"subject":[]}}